193 related articles for article (PubMed ID: 10603485)
1. Interactions between mycoplasma lipoproteins and the host immune system.
Chambaud I; Wróblewski H; Blanchard A
Trends Microbiol; 1999 Dec; 7(12):493-9. PubMed ID: 10603485
[TBL] [Abstract][Full Text] [Related]
2. Elongated versions of Vlp surface lipoproteins protect Mycoplasma hyorhinis escape variants from growth-inhibiting host antibodies.
Citti C; Kim MF; Wise KS
Infect Immun; 1997 May; 65(5):1773-85. PubMed ID: 9125561
[TBL] [Abstract][Full Text] [Related]
3. The central role of lipoproteins in the pathogenesis of mycoplasmoses.
Browning GF; Marenda MS; Noormohammadi AH; Markham PF
Vet Microbiol; 2011 Nov; 153(1-2):44-50. PubMed ID: 21684094
[TBL] [Abstract][Full Text] [Related]
4. Immunological interactions between host cells and mycoplasmas: an introduction.
Fernald GW
Rev Infect Dis; 1982; 4 Suppl():S201-4. PubMed ID: 6750755
[TBL] [Abstract][Full Text] [Related]
5. The Vlp system of Mycoplasma hyorhinis: combinatorial expression of distinct size variant lipoproteins generating high-frequency surface antigenic variation.
Rosengarten R; Wise KS
J Bacteriol; 1991 Aug; 173(15):4782-93. PubMed ID: 1856172
[TBL] [Abstract][Full Text] [Related]
6. Phase and antigenic variation in mycoplasmas.
Citti C; Nouvel LX; Baranowski E
Future Microbiol; 2010 Jul; 5(7):1073-85. PubMed ID: 20632806
[TBL] [Abstract][Full Text] [Related]
7. Phenotypic switching in mycoplasmas: phase variation of diverse surface lipoproteins.
Rosengarten R; Wise KS
Science; 1990 Jan; 247(4940):315-8. PubMed ID: 1688663
[TBL] [Abstract][Full Text] [Related]
8. Interaction of mycoplasmas with host cells.
Rottem S
Physiol Rev; 2003 Apr; 83(2):417-32. PubMed ID: 12663864
[TBL] [Abstract][Full Text] [Related]
9. Interactions between mycoplasma lipid-associated membrane proteins and the host cells.
You XX; Zeng YH; Wu YM
J Zhejiang Univ Sci B; 2006 May; 7(5):342-50. PubMed ID: 16615163
[TBL] [Abstract][Full Text] [Related]
10. [Antigenic variation in Mycoplasmas].
Rivera-Tapia JA
Gac Med Mex; 2002; 138(3):289-90. PubMed ID: 12102047
[No Abstract] [Full Text] [Related]
11. Mycoplasma host-cell interactions resulting in chronic inflammation: acquisition of host antigens and other mechanisms.
Davis JK; Cassell GH; Minion FC; Wise KS
Isr J Med Sci; 1981 Jul; 17(7):633-6. PubMed ID: 6974722
[TBL] [Abstract][Full Text] [Related]
12. Beware of Mycoplasma Anti-immunoglobulin Strategies.
Arfi Y; Lartigue C; Sirand-Pugnet P; Blanchard A
mBio; 2021 Dec; 12(6):e0197421. PubMed ID: 34781733
[TBL] [Abstract][Full Text] [Related]
13. Mycoplasmas and HIV infection: from epidemiology to their interaction with immune cells.
Brenner C; Neyrolles O; Blanchard A
Front Biosci; 1996 Aug; 1():e42-54. PubMed ID: 9159244
[TBL] [Abstract][Full Text] [Related]
14. Effects of mycoplasma infection on the host organism response via p53/NF-κB signaling.
Borchsenius SN; Daks A; Fedorova O; Chernova O; Barlev NA
J Cell Physiol; 2018 Jan; 234(1):171-180. PubMed ID: 30146800
[TBL] [Abstract][Full Text] [Related]
15. Characterization of membrane surface proteins of Mycoplasma agalactiae during natural infection.
Tola S; Manunta D; Cocco M; Turrini F; Rocchigiani AM; Idini G; Angioi A; Leori G
FEMS Microbiol Lett; 1997 Sep; 154(2):355-62. PubMed ID: 9311134
[TBL] [Abstract][Full Text] [Related]
16. The phagocytosis of mycoplasmas.
Marshall AJ; Miles RJ; Richards L
J Med Microbiol; 1995 Oct; 43(4):239-50. PubMed ID: 7562984
[No Abstract] [Full Text] [Related]
17. Subversion and exploitation of host cells by mycoplasmas.
Rottem S; Naot Y
Trends Microbiol; 1998 Nov; 6(11):436-40. PubMed ID: 9846360
[TBL] [Abstract][Full Text] [Related]
18. [Interaction of Mycoplasma with immune system of animals and humans].
Borkhsenius SN; Chernova OA; Chernov VM
Tsitologiia; 2001; 43(3):219-43. PubMed ID: 11387752
[TBL] [Abstract][Full Text] [Related]
19. Interactions of mycoplasmas with B cells: antibody production and nonspecific effects.
Simecka JW; Ross SE; Cassell GH; Davis JK
Clin Infect Dis; 1993 Aug; 17 Suppl 1():S176-82. PubMed ID: 8399911
[TBL] [Abstract][Full Text] [Related]
20. Vpma phase variation is important for survival and persistence of Mycoplasma agalactiae in the immunocompetent host.
Chopra-Dewasthaly R; Spergser J; Zimmermann M; Citti C; Jechlinger W; Rosengarten R
PLoS Pathog; 2017 Sep; 13(9):e1006656. PubMed ID: 28957426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
